| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -2.5e-05 | 1 |